HSBC Holdings’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-177,477
| Closed | -$7.49M | – | 2907 |
|
|
2023
Q2 | $7.49M | Buy |
177,477
+161,737
| +1,028% | +$6.54M | 0.01% | 908 |
|
|
2023
Q1 | $561K | Sell |
15,740
-34,055
| -68% | -$1.24M | ﹤0.01% | 1999 |
|
|
2022
Q4 | $1.81M | Buy |
49,795
+20,988
| +73% | +$830K | ﹤0.01% | 1728 |
|
|
2022
Q3 | $1.38M | Buy |
28,807
+562
| +2% | +$36.3K | ﹤0.01% | 1696 |
|
|
2022
Q2 | $2.05M | Sell |
28,245
-19,604
| -41% | -$1.43M | ﹤0.01% | 1574 |
|
|
2022
Q1 | $3.94M | Buy |
47,849
+40,424
| +544% | +$3.42M | ﹤0.01% | 1277 |
|
|
2021
Q4 | $765K | Sell |
7,425
-37,081
| -83% | -$3.56M | ﹤0.01% | 2197 |
|
|
2021
Q3 | $3.91M | Buy |
44,506
+23,234
| +109% | +$2.1M | ﹤0.01% | 1251 |
|
|
2021
Q2 | $1.91M | Buy |
21,272
+6,450
| +44% | +$545K | ﹤0.01% | 1468 |
|
|
2021
Q1 | $1.14M | Buy |
14,822
+5,456
| +58% | +$411K | ﹤0.01% | 1523 |
|
|
2020
Q4 | $637K | Sell |
9,366
-11,705
| -56% | -$730K | ﹤0.01% | 2015 |
|
|
2020
Q3 | $1.13M | Buy |
21,071
+5,324
| +34% | +$317K | ﹤0.01% | 1498 |
|
|
2020
Q2 | $917K | Sell |
15,747
-33,408
| -68% | -$1.8M | ﹤0.01% | 1498 |
|
|
2020
Q1 | $1.96M | Buy |
49,155
+34,874
| +244% | +$2.04M | ﹤0.01% | 1189 |
|
|
2019
Q4 | $853K | Buy |
14,281
+117
| +0.8% | +$6.29K | ﹤0.01% | 1924 |
|
|
2019
Q3 | $754K | Buy |
14,164
+5,747
| +68% | +$295K | ﹤0.01% | 2099 |
|
|
2019
Q2 | $430K | Buy |
8,417
+2,987
| +55% | +$139K | ﹤0.01% | 2140 |
|
|
2019
Q1 | $282K | Sell |
5,430
-1,842
| -25% | -$89.3K | ﹤0.01% | 2381 |
|
|
2018
Q4 | $287K | Sell |
7,272
-145
| -2% | -$6.74K | ﹤0.01% | 2315 |
|
|
2018
Q3 | $382K | Buy |
7,417
+1,131
| +18% | +$55.4K | ﹤0.01% | 2137 |
|
|
2018
Q2 | $295K | Buy |
+6,286
| New | +$260K | ﹤0.01% | 2288 |
|
|
2018
Q1 | – | Sell |
-8,311
| Closed | -$362K | – | 2613 |
|
|
2017
Q4 | $362K | Buy |
8,311
+2,778
| +50% | +$130K | ﹤0.01% | 1632 |
|
|
2017
Q3 | $289K | Buy |
5,533
+626
| +13% | +$34.9K | ﹤0.01% | 1963 |
|
|
2017
Q2 | $287K | Sell |
4,907
-30
| -0.6% | -$1.56K | ﹤0.01% | 1900 |
|
|
2017
Q1 | $226K | Sell |
4,937
-6,921
| -58% | -$344K | ﹤0.01% | 1935 |
|
|
2016
Q4 | $623K | Buy |
11,858
+7,000
| +144% | +$339K | ﹤0.01% | 1670 |
|
|
2016
Q3 | $217K | Buy |
+4,858
| New | +$211K | ﹤0.01% | 1902 |
|
|
2015
Q4 | – | Sell |
-7,817
| Closed | -$312K | – | 2280 |
|
|
2015
Q3 | $312K | Buy |
7,817
+698
| +10% | +$30.5K | ﹤0.01% | 1597 |
|
|
2015
Q2 | $285K | Buy |
+7,119
| New | +$246K | ﹤0.01% | 1642 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
HSBC Holdings's SYNH Position: Q3 2023 in Review
HSBC Holdings sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 177,477 shares — an estimated $7.49M sold.
HSBC Holdings first reported a position in SYNH in Q2 2015 and held it in 29 quarters. The position peaked at $7.49M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- HSBC Holdings reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- HSBC Holdings sold 177,477 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $7.49M.
- HSBC Holdings first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 29 quarters.
- HSBC Holdings's Syneos Health, Inc. Class A Common Stock position peaked at $7.49M in Q2 2023.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.